MDT

95.64

+0.65%↑

VEEV

290.14

+2.57%↑

A

145.46

+0.92%↑

HQY

95.8

+3.62%↑

TLRY

1.52

-5%↓

MDT

95.64

+0.65%↑

VEEV

290.14

+2.57%↑

A

145.46

+0.92%↑

HQY

95.8

+3.62%↑

TLRY

1.52

-5%↓

MDT

95.64

+0.65%↑

VEEV

290.14

+2.57%↑

A

145.46

+0.92%↑

HQY

95.8

+3.62%↑

TLRY

1.52

-5%↓

MDT

95.64

+0.65%↑

VEEV

290.14

+2.57%↑

A

145.46

+0.92%↑

HQY

95.8

+3.62%↑

TLRY

1.52

-5%↓

MDT

95.64

+0.65%↑

VEEV

290.14

+2.57%↑

A

145.46

+0.92%↑

HQY

95.8

+3.62%↑

TLRY

1.52

-5%↓

Search

Immunocore Holdings PLC ADR

Aperta

33.66 0.51

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

32.58

Massimo

33.99

Metriche Chiave

By Trading Economics

Entrata

-15M

-10M

Vendite

4.1M

98M

Margine di Profitto

-10.514

Dipendenti

493

EBITDA

-11M

-15M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+76.13% upside

Dividendi

By Dow Jones

Utili prossimi

4 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2M

1.6B

Apertura precedente

33.15

Chiusura precedente

33.66

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bearish Evidence

Immunocore Holdings PLC ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 ott 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for Takaichi's Policy Steps -- Market Talk

20 ott 2025, 23:43 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

20 ott 2025, 23:36 UTC

Discorsi di Mercato

Gold Edges Higher on Likely Dip-Buying Interest -- Market Talk

20 ott 2025, 22:14 UTC

Discorsi di Mercato

Zions Management Confident $50M Charge Was Isolated Event -- Market Talk

20 ott 2025, 22:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Berkshire May Have Left $50 Billion on Table. Apple Stock Hit a Record. -- Barrons.com

20 ott 2025, 21:49 UTC

Acquisizioni, Fusioni, Takeovers

Kering Sells Beauty Business to L'Oréal. Everyone but This Company Wins. -- Barrons.com

20 ott 2025, 20:56 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Moved the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20 ott 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

20 ott 2025, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

20 ott 2025, 20:38 UTC

Utili

Steel Dynamics: Encouraging Demand Drivers of Manufacturing Onshoring, Infrastructure Program Funding, Lower Interest Rates, Increasing Regionalization of Supply Chains in U.S. >STLD

20 ott 2025, 20:38 UTC

Utili

Steel Dynamics: Expect to Benefit From Stronger Demand Across Platforms, Including Aluminum Flat Rolled Products, as We Move Into 2026 >STLD

20 ott 2025, 20:38 UTC

Utili

Steel Dynamics: Some Order Hesitancy From Flat Rolled Steel Customers Due to Domestic Trade Actions >STLD

20 ott 2025, 20:36 UTC

Utili

Steel Dynamics: Continue to Observe Some Customer Inventory Overhang of Value-Added Flat Rolled Products That Were Imported Earlier This Yr >STLD

20 ott 2025, 20:36 UTC

Utili

Steel Dynamics: View U.S. Intl Trade Commission's Final Determinations on Coated Flat Rolled Steel as a Significant Positive Development >STLD

20 ott 2025, 20:36 UTC

Utili

Steel Dynamics: Discussions With Customers Reinforce the Increasing Importance of Low-Carbon, U.S.-Made Steel and Aluminum, Positioning Our Businesses for a Long-Term Competitive Advantage >STLD

20 ott 2025, 20:36 UTC

Utili

Steel Dynamics: Improving Market Conditions, Including Increased Trade Stability and Favorable Interest Rate Environment, Will Contribute to Strong Domestic Demand for Steel and Aluminum >STLD

20 ott 2025, 20:16 UTC

Discorsi di Mercato

Canada Labor-Market Indicators Lean Dovish -- Market Talk

20 ott 2025, 20:05 UTC

Utili

GE Aerospace Earnings Are on Tap. After the Turnaround, Investors Wonder What's Next. -- Barrons.com

20 ott 2025, 19:39 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Industrials Post Positive Earnings. 3 Stocks Whose Charts Say 'Buy.' -- Barrons.com

20 ott 2025, 19:34 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Jump on Colder Weather Outlook -- Market Talk

20 ott 2025, 19:32 UTC

Discorsi di Mercato

Oil Futures Extend Losses on Oversupply Concerns -- Market Talk

20 ott 2025, 19:00 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20 ott 2025, 18:29 UTC

Discorsi di Mercato

Apple Sitting on Best Long-Term Product Roadmap in Years -- Market Talk

20 ott 2025, 18:11 UTC

Discorsi di Mercato

Economic Vital Signs Missing in Bank of Canada Survey -- Market Talk

20 ott 2025, 18:04 UTC

Discorsi di Mercato

Uncertainty Remains Top Concern Among Canada Firms -- Market Talk

20 ott 2025, 17:03 UTC

Discorsi di Mercato

Weak Demand Signals Narrower Profit Margins For Canada Firms -- Market Talk

20 ott 2025, 17:01 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

20 ott 2025, 17:01 UTC

Discorsi di Mercato

Bank of Canada Surveys Present Shaky Economic Outlook -- Market Talk

20 ott 2025, 16:43 UTC

Discorsi di Mercato

Canada Public-Sector Workers Fret Most On Labor-Market Weakness -- Market Talk

20 ott 2025, 16:25 UTC

Discorsi di Mercato

U.S. Natural Gas Extends Rebound on Weather Outlook -- Market Talk

Confronto tra pari

Modifica del prezzo

Immunocore Holdings PLC ADR Previsione

Obiettivo di Prezzo

By TipRanks

76.13% in crescita

Previsioni per 12 mesi

Media 59.11 USD  76.13%

Alto 100 USD

Basso 34 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Immunocore Holdings PLC ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

7

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

27.895 / 30.16Supporto e resistenza

A breve termine

Weak Bearish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Weak Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Immunocore Holdings PLC ADR

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
help-icon Live chat